CorMedix (CRMD) Raw Materials (2019 - 2025)

CorMedix has reported Raw Materials for 5 years, with the latest figure at $3.6 million in Q4 2025.

• Quarterly Raw Materials rose 227.18% year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (up 227.18% YoY) and the FY2025 annual result came in at $3.6 million, up 227.18% from the prior year.
• Raw Materials declined to $3.6 million in Q4 2025 per CRMD's latest filing, from $7.0 million in the prior quarter.
• Over five years, Raw Materials peaked at $7.0 million in Q3 2025 and troughed at $603545.0 in Q3 2024.
• A 3-year average of $2.1 million and a median of $1.1 million in 2025 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2024 and 2025: Raw Materials declined 27.17% in 2024, then soared 1062.75% in 2025.
• Over 3 years, Raw Materials stood at $1.5 million in 2023, then dropped by 27.17% to $1.1 million in 2024, then surged by 227.18% to $3.6 million in 2025.
• According to Business Quant data, Raw Materials over the past three periods registered $3.6 million, $7.0 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.